Back to Awarded Treatment Trials
Awarded Trial: 99-188
Grant ID
99-188
Illness
Schizophrenia
Primary Drug/Intervention
Clozapine
Primary Dosage
300 mg/day
Secondary Drug Intervention
Quetiapine
Secondary Dosage
400 mg/day
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Byerly
Sample Size
64
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
PANSS, CGI Severity and Change Scale, HAM-D, Simpson-Angus, Barnes Akathisia, AIMS Scale, and Heinrichs-Carpenter Quality of Life Scale.
Results
The grant was terminated.
Publication
N/A
Link
N/A
PI Name
Matthew Byerly
Degree
MD
Center
N/A
Institution
UT Southwestern Medical Center
Address
5959 Harry Hines Blvd
City or Town
Dallas
State or Province
TX
Zip or Postal Code
75235-9101
Country
USA
Email Address
mbyerl@mednet.swmed.edu